Gozalbo D, Elorza M V, Sanjuan R, Marcilla A, Valentín E, Sentandreu R
Secció de Microbiologia, Facultat de Farmàcia, Universitat de València, Spain.
Pharmacol Ther. 1993 Nov;60(2):337-45. doi: 10.1016/0163-7258(93)90015-6.
Development of new effective antifungal drugs is limited by the absence of specific target sites in the fungal cells. Knowledge of the fungal cell wall structure and biosynthesis is of interest in searching for a potential target site for new chemotherapeutic agents. Our group has demonstrated that the fungal cell wall is a metabolically active structure where interaction between distinct components occurs to give rise to the mature cell wall structure. Mannoproteins play an essential role in the cell wall organization, and there is evidence for the formation of covalent bonds between these molecules and the structural polymers (glucans and chitin) outside the plasma membrane. Such interactions, which specifically occur at the fungal cell wall, are of great interest in defining target sites for potential new chemotherapeutic agents, which may inhibit the interactions and, thus, lead to a defective cell wall formation and cell death.
新型有效抗真菌药物的研发受到真菌细胞中缺乏特异性靶点的限制。了解真菌细胞壁的结构和生物合成对于寻找新型化疗药物的潜在靶点具有重要意义。我们的研究小组已经证明,真菌细胞壁是一个代谢活跃的结构,不同组分之间相互作用形成成熟的细胞壁结构。甘露糖蛋白在细胞壁组织中起重要作用,有证据表明这些分子与质膜外的结构聚合物(葡聚糖和几丁质)之间形成了共价键。这种特异性发生在真菌细胞壁上的相互作用,对于确定潜在新型化疗药物的靶点非常重要,这些药物可能抑制这种相互作用,从而导致细胞壁形成缺陷和细胞死亡。